Anti-lymphoplus anti-monocytes globulin preparation for inhibiting immunes responses

Details for Australian Patent Application No. 2005287392 (hide)

Owner Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services

Inventors Xu, He; Kirk, Allan D.

Agent Pizzeys

Pub. Number AU-A-2005287392

PCT Pub. Number WO2006/033688

Priority 60/581,201 18.06.04 US

Filing date 16 June 2005

Wipo publication date 30 March 2006

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 5/12 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Fused cells, e.g. hybridomas

Event Publications

11 January 2007 PCT application entered the National Phase

  PCT publication WO2006/033688 Priority application(s): WO2006/033688

20 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005287393-AAV mediated gene delivery to cochlear cells

2005287383-Self-assembling nanoparticle drug delivery system